151 related articles for article (PubMed ID: 28863410)
1. Appearance of Abnormal Cardiothoracic Ratio of Fetuses with Hemoglobin Bart's Disease: Life Table Analysis.
Wanapirak C; Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Ultraschall Med; 2017 Oct; 38(5):544-548. PubMed ID: 28863410
[No Abstract] [Full Text] [Related]
2. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity.
Srisupundit K; Piyamongkol W; Tongsong T
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):694-7. PubMed ID: 19350531
[TBL] [Abstract][Full Text] [Related]
3. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation.
Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Prenat Diagn; 2014 Mar; 34(3):230-4. PubMed ID: 24318930
[TBL] [Abstract][Full Text] [Related]
4. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Piyamongkol W; Tongprasert F; Srisupundit K; Luewan S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Performances of Middle Cerebral Artery Peak Systolic Velocity and Cardiothoracic Diameter Ratio in Predicting Fetal Anemia: Using Fetal Hemoglobin Bart's Disease as a Study Model.
Chankhunaphas W; Tongsong T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P
Fetal Diagn Ther; 2021; 48(10):738-745. PubMed ID: 34794140
[TBL] [Abstract][Full Text] [Related]
6. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Dec; 34(13):1277-82. PubMed ID: 25046597
[TBL] [Abstract][Full Text] [Related]
7. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
Srisupundit K; Piyamongkol W; Tongsong T
Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of ultrasound algorithm in prenatal diagnosis of hemoglobin Bart's disease among pregnancies at risk.
Harn-A-Morn P; Wanapirak C; Sirichotiyakul S; Srisupundit K; Tongprasert F; Luewan S; Tongsong T
Int J Gynaecol Obstet; 2022 Nov; 159(2):451-456. PubMed ID: 35152406
[TBL] [Abstract][Full Text] [Related]
9. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
[TBL] [Abstract][Full Text] [Related]
10. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
Lam YH; Tang MH
Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
[TBL] [Abstract][Full Text] [Related]
12. Fetal myocardial performance (Tei) index in fetal hemoglobin Bart's disease.
Luewan S; Tongprasert F; Srisupundit K; Tongsong T
Ultraschall Med; 2013 Aug; 34(4):355-8. PubMed ID: 23386484
[TBL] [Abstract][Full Text] [Related]
13. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
[TBL] [Abstract][Full Text] [Related]
14. An increase of the cardiothoracic ratio leads to a diagnosis of Bart's hydrops.
Phupong V
J Med Assoc Thai; 2006 Apr; 89(4):509-12. PubMed ID: 16696397
[TBL] [Abstract][Full Text] [Related]
15. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
16. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Wanapirak C; Sirichotiyakul S
Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
[TBL] [Abstract][Full Text] [Related]
17. Performance of Fetal Cardiac Volume Derived from VOCAL (Virtual Organ Computer-Aided AnaLysis) in Predicting Hemoglobin (Hb) Bart's Disease.
Thammavong K; Luewan S; Tongsong T
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682774
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cardiac findings using speckle tracking in fetuses with hemoglobin Bart's disease.
Anuwutnavin S; Russameecharoen K; Ruangvutilert P; Viboonchard S; Yaiyiam C; Sklansky M; DeVore GR
Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38706423
[TBL] [Abstract][Full Text] [Related]
19. Comparing three cardiothoracic ratio measurement techniques and creating multivariable scoring system to predict Bart's hydrops fetalis at 17-22 weeks' gestation.
Anuwutnavin S; Rangseechamrat P; Sompagdee N; Ruangvutilert P; Viboonchard S
Sci Rep; 2024 Apr; 14(1):8894. PubMed ID: 38632453
[TBL] [Abstract][Full Text] [Related]
20. Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease.
Luewan S; Apaijai N; Chattipakorn N; Chattipakorn SC; Tongsong T
BMC Pregnancy Childbirth; 2024 Feb; 24(1):141. PubMed ID: 38365664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
